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Abstract
Purpose This study aimed to investigate the frequency and
characteristics of childhood-onset uveitis and evaluate the
rate and specific causes of visual loss in this population.
Methods The data of 121 patients (179 eyes) with uveitis
starting before ≤16 years and followed up for at least
6 months were retrospectively evaluated. Age at onset, sex,
laterality, associated systemic disease, laboratory data,
therapeutic strategies, surgeries, final visual acuity, and
causes leading to visual acuity ≤20/200 were analyzed.
Results Childhood-onset uveitis made up 9.6% of our
uveitis patients. The mean age at onset was 11.7 years (1–
16) and the mean follow-up period was 38.5 months (6–
148). Forty-three patients (35.5%) were female and 78 were
male (64.5%). The disease was bilateral in 58 (47.9%) and
unilateral in 63 (52.1%) patients. Uveitis was mostly
(59.5%) seen between 12 and 16 years of age. Pars planitis,
observed in 29 (24%) patients, was the leading cause of
childhood-onset uveitis. Uveitis was idiopathic in 20
(16.5%) of patients. The most frequently associated
diseases were Behcet’s disease (BD) in 20 (16.5%),
toxoplasmosis in 16 (13.2%), and juvenile idiopathic
arthritis (JIA) in 8 (6.6%) patients. Anterior uveitis was
observed in 38 (31.4%), intermediate uveitis in 31 (25.6%),
posterior uveitis in 30 (24.8%), and panuveitis in 22
(18.2%) patients. The final visual acuity was ≤20/200 in
32/179 eyes (17.9%) of 27/121 patients (22.3%). The most
often ocular complication leading to visual acuity ≤20/200
was optic atrophy and had been observed in 14 of 32 eyes
(43.7%). Macular scar observed in five eyes (15.6%) was
the second most often complication. Etiological distribution
of 27 patients with visual acuity ≤20/200 was as follows: 12
had BD (44.4%), 5 had idiopathic uveitis (18.5%), 4 had
pars planitis (14.8%), 3 had toxoplasmosis (11.1%), 2 had
JIA (7.4%), and 1 had toxocara (3.7%).
Conclusions Although rare, childhood-onset uveitis has a
blinding potential and causes visual loss in up to 22.3% of
the patients. In endemic areas like Turkey, BD may be the
most common uveitis-associated systemic disease and the
leading cause of visual loss in childhood uveitis as
adulthood.
Keywords Epidemiology.Childhood.Pediatric.Uveitis.
Complications.Prognosis
Introduction
Although uveitis is less common (5–10%) in children, the
prognosis is nevertheless poorer [1]. Uveitis may be
asymptomatic either because of the preverbal age of the
children or the insidious nature of the disease [2–4].
Because the course of the disease is frequently chronic
and the diagnosis is often delayed, children have a higher
risk of complications [4]. The presence of severe ocular
complications at the initial presentation is common [2]. The
management of uveitis is associated with unique problems
because of the patient’s immature immune system and
developing skeletal and reproductive systems [3]. The
incidence and associated systemic diseases show differ-
ences that may be due to geographic, genetic, demographic
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DOI 10.1007/s12348-011-0044-8factors, and also to different referral patterns and definition
of pediatric age range [3, 5]. Hence, pediatric uveitis is still
a challenge for ophthalmologists. This study aimed to
investigate the characteristics of childhood-onset uveitis
and evaluate the rate and specific causes of visual loss in
this particular population.
Material and methods
We retrospectively evaluated the medical records of 1,265
uveitis patients presented at Uveitis and Behçet’s Disease
Department of Ulucanlar Eye Hospital between January
1996 and May 2008 and retrieved 121 patients with uveitis
starting before or at 16 years of age. All patients were
immunocompetent. Patients with a follow-up period less
than 6 months were excluded from the study. Age at onset,
laterality and anatomic localization of uveitis, gender,
follow-up period, associated systemic diseases, laboratory
data, therapeutic strategies, performed surgical interven-
tions, ocular complications, final visual acuity, and causes
leading to visual acuity ≤20/200 were analyzed.
All patients underwent a clinical examination including
visual acuity testing with Snellen chart, intraocular pressure
measurement, biomicroscopy, and fundus examination
through a dilated pupil by a 90D lens. Fundus fluorescein
angiography, ultrasonography, and optical coherence to-
mography were performed when indicated. Routine labo-
ratory evaluation consisted of a complete blood count with
differential, biochemical analysis, urinalysis, and erythro-
cyte sedimentation rate. Antinuclear antibody, rheumatoid
factor, C-reactive protein, human leukocyte antigen (HLA)
typing, angiotensin-converting enzyme, pathergy test, skin
tuberculin test, chest radiography, syphilis, toxoplasma,
herpes, and lyme serology were done in selected patients.
Patients were consulted with pediatricians or pediatric
rheumatologists according to clinical findings.
Patients were classified as having anterior, intermediate,
posterior, and panuveitis according to Standardization of
Uveitis Nomenclature Working Group recommendations
[6]. If the primary site of the inflammation was anterior
chamber, then the uveitis was anterior, if the vitreous was
the primary site, then the uveitis was intermediate, and if
retina or choroid was primarily involved, then the uveitis
was posterior. Uveitis involving all of these anatomical
parts was diagnosed as panuveitis. Pars planitis was
considered as a specific uveitis entity and this term was
used only for intermediate uveitis where there is a
snowbank or snowball formation occurring in the absence
of an associated infection or systemic disease (that is,
“idiopathic”). If there is an associated infection or systemic
disease, then the term intermediate uveitis was used. The
diagnosis of ocular toxoplasmosis and toxocariasis was
based on typical clinical features and confirmed by positive
serology. Patients having uveitis without an associated
systemic disease, laboratory abnormality, or well-
established specific uveitis entity such as Fuchs' uveitis,
pars planitis, and herpetic uveitis were considered to be
idiopathic. Uveitis with sudden onset lasting ≤3 months
was considered as acute, and uveitis lasting longer than
3 months and relapsing in <3 months after discontinuation
of treatment was considered as chronic uveitis. The
diagnosis of Behçet’s disease was made according to the
criteria of the International Study Group for Behçet’s
Disease [7].
Treatment modalities applied to treat either uveitis or its
complications were classified as topical, systemic, perioc-
ular, intraocular, and surgical. Medical treatment was
instituted regarding the etiology and the severity of uveitis.
Surgical treatment included cataract extraction, pars plana
vitrectomy, pars plana lensectomy, glaucoma surgery,
chelation with ethyldiamietetraacetic acid (EDTA), and
peripheral cryotherapy.
Results
Cases of childhood-onset uveitis made up 9.6% (121/1265)
of our uveitis patients. Forty-five patients (37.2%) were
female and 76 (62.8%) were male. Mean age at onset of
uveitis was 11.7±3.6 years (range 1–16). Of 121 patients,
72 (59.5%) were between 12 and 16, 41 (33.9%) were
between 6 and 11, and 8 (6.6%) were between 0 and 5 years
old. Thus, the uveitis was mostly seen between 12 and
16 years of age. The mean follow-up period was 38.5±
3.2 months (6–148).
Uveitis was infectious in 26 patients (21.5%) and
noninfectious in 95 (78.5%) patients. Pars planitis was
found to be the most common cause of uveitis (29 patients,
24%) in pediatric cases. Uveitis was idiopathic in 20
(16.5%) patients and BD was the most frequently associ-
ated systemic disease (20 patients, 16.5%). Toxoplasmosis
observed in 16 patients (13.2%) was the most common
cause of posterior and infectious uveitis. Other less
common causes of uveitis were JIA (eight patients, 6.6%),
herpes infection (five patients, 4.1%), and ankylosing
spondilitis (five patients, 4.1%). Table 1 shows etiologies
of uveitis and their distribution by gender.
Anterior uveitis was observed in 38 (31.4%), intermedi-
ate uveitis in 31 (25.6%), posterior uveitis in 30 (24.8%),
and panuveitis in 22 (18.2%) patients. While idiopathic
uveitis and JIA were the most common causes of anterior
uveitis, toxoplasmosis was the leading cause of posterior
uveitis. Panuveitis was mostly observed in BD-associated
uveitis. Table 2 shows anatomic localization of uveitis
according to etiology.
14 J Ophthal Inflamm Infect (2012) 2:13–19The disease was bilateral in 58/121 (47.9%) patients
resulting in 179 affected eyes. Herpetic uveitis (5/5, 100%),
ocular toxoplasmosis (15/16, 93.7%), and idiopathic uveitis
(12/20, 60%) had a tendency to be unilateral, whereas
ocular BD (12/20, 60%) and pars planitis (25/29, 86.2%)
had a tendency to be bilateral. Uveitis was acute in 39
(32.2%) and chronic in 82 (67.8%) patients.
Laboratory evaluation showed HLA B51 positivity in 18
(14.9%) patients in whom nine (50%) had BD-associated
uveitis. Thus, the rate of HLA B51 positivity was 45% (9/
20 patients) in BD patients. HLA B27 was positive in three
patients with ankylosing spondylitis and HLA DR15 was
positive in five patients with pars planitis. Toxoplasmosis
IgG was positive and IgM negative in all patients with
ocular toxoplasmosis. Herpes simplex virus type I IgM was
positive in one and IgG in two patients with herpetic
uveitis. Antinuclear antibody was positive in two patients
with JIA-associated uveitis and one patient with pars
Table 1 Etiology of uveitis by gender and laterality
Diagnosis Female Male Unilateral Bilateral No. of patients (%) No. of eyes (%)
Pars planitis 8 21 4 25 29 (23.9) 54 (30.2)
Idiopathic uveitis 8 12 12 8 20 (16.5) 28 (15.6)
Behcet’s disease 8 12 8 12 20 (16.5) 32 (17.8)
Toxoplasmosis 10 6 15 1 16 (13.2) 17 (9.5)
JIA 4 4 4 4 8 (6.6) 12 (6.7)
Herpetic uveitis 1 4 5 – 5 (4.1) 5 (2.8)
Ankylosing spondilitis 2 3 2 3 5 (4.1) 8 (4.5)
Toxocara 4 4 – 4 (3.3) 4 (2.2)
Fuchs’ uveitis 3 3 – 3 (2.5) 3 (1.7)
Traumatic iritis 3 3 – 3 (2.5) 3 (1.7)
FMF 2 – 2 2 (1.6) 4 (2.2)
Multifocal choroiditis 1 1 2 – 2 (1.6) 2 (1.1)
Sarcoidosis 1 – 1 1 (0.8) 2 (1.1)
Brucella 1 1 – 1 (0.8) 1 (0.5)
VKH 1 – 1 1(0.8) 2 (1.1)
Diabetic iritis 1 – 1 1 (0.8) 2 (1.1)
Total 45 76 63 58 121 (100) 179 (100)
JIA juvenile idiopathic arthritis, FMF Familial Mediterranean Fever, VKH Vogt–Koyanagi–Harada disease
Table 2 Anatomic localization
of uveitis according to etiology
JIA juvenile idiopathic arthritis,
FMF Familial Mediterranean
Fever, VKH Vogt–Koyanagi–
Harada disease
Diagnosis Anterior Intermediate Posterior Panuveitis
Pars planitis 27 2
Idiopathic uveitis 10 1 4 5
Behcet’s disease 4 2 4 10
Toxoplasmosis 14 2
JIA 6 2
Herpetic uveitis 5
Ankylosing spondilitis 5
Toxocara 4
Fuchs’ uveitis 3
Traumatic iritis 3
FMF 1 1
Multifocal choroiditis 2
VKH 1
Brucella 1
Diabetic iritis 1
Sarcoidosis 1
38 (31.4%) 31 (25.6%) 30 (24.8%) 22 (18.2%)
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four patients in whom two had the diagnosis of pars
planitis, one sarcoidosis, and one idiopathic uveitis.
Complications secondary to uveitis were cataract (38
eyes, 21.2%), glaucoma (32 eyes, 17.8%), cystoid macular
edema (CME) (17 eyes, 9.5%), vitreous condensation (15
eyes, 8.4%), optic atrophy (14 eyes, 7.8%), band keratop-
athy (13 eyes, 7.3%), posterior capsule opacification, retinal
detachment and macular scar (5 eyes, 2.8% for each),
pupillary occlusion (3 eyes, 1.8%), macular hole, and
neovascularization of the disc (1 eye, 0.6% for each)
(Table 3).
Topical treatment was needed in 73 patients (60.3%).
Systemic treatment included immunosuppressive and/or
immunomodulator therapy in 32 patients [14 with BD, 7
JIA, 8 pars planitis, 1 ankylosing spondylitis, 1 Familial
Mediterranean Fever (FMF), and 1 Vogt–Koyanagi–Harada
disease (VKH)], antibiotic therapy in 10 patients (9 with
ocular toxoplasmosis and 1 brucellosis), and antiherpes
therapy in 3 patients. Systemic corticosteroids were used in
23 patients in combination with either immunosuppressive
agents or antibiotics.
Posterior subtenon injections of triamcinolone acetonide in
50 (27.9%), intravitreal injections of triamcinolone acetonide
in 9 (5%), and intravitreal injection of bevacizumab in 3
(1.7%) eyes were performed. Laser photocoagulation (four
eyes, 2.2%) and Nd-YAG capsulotomy (ten eyes, 5.6%) were
applied in required cases.
Performed surgeries were as follows: cataract extraction
with or without intraocular lens implantation (22 eyes,
12.3%), pars plana vitrectomy (14 eyes, 7.8%), trabeculec-
tomy (6 eyes, 3.3%), EDTA scrub (3 eyes, 1.7%), retinal
detachment surgery (2 eyes, 1.1%), pars plana vitrectomy
and lensectomy (1 eye, 0.6%), enucleation (1 eye, 0.6%),
and intraocular lens extraction (1 eye, 0.6%). Some of these
surgeries were performed in our clinic during the follow-up
period, but some were already performed at the time of
presentation. We did not implant intraocular lens to children
with JIA and a child with VKH having chronic inflammation
with pupillary occlusion. Intraocular lens was implanted to
patients with BD, pars planitis, Fuchs’ uveitis, FMF, and
idiopathic uveitis in order to be quiet for at least 3 months. A
painful eye with phthisis bulbi due to BD-associated uveitis
and neovascular glaucoma was enucleated.
Visual acuities at first presentation to our Uveitis and
Behçet’s Disease Department were ≥20/32 in 97 eyes
(54.2%), between 20/100 and 20/40 in 45 eyes (25.1%),
and ≤20/200 in 37 eyes (20.7%). The number of patients
having visual acuity ≤20/200 in at least one eye was 29
(24%).
Visual acuities at last visit were ≥20/32 in 125 eyes
(69.8%), between 20/100 and 20/40 in 22 eyes (12.3%),
and ≤20/200 in 32 eyes (17.9%). The number of patients
having final visual acuity ≤20/200 in at least one eye was
27 (22.3%). Of these 27 patients, 10 had BD (37%), 5 had
idiopathic panuveitis (18.5%), 5 had pars planitis (18.5%),
4 had ocular toxoplasmosis (14.8%), 2 had JIA-associated
panuveitis (7.4%), and 1 had toxocara (3.7%). Thus, 22 of
27 patients (81.5%) had either panuveitis or posterior
uveitis. Optic atrophy was the main cause of visual loss
and has been observed in 14 eyes (43.7%). Ten of 14 eyes
with optic atrophy had BD-related posterior or panuveitis.
Others were toxocara (one eye), VKH (one eye), brucella
(one eye), and idiopathic panuveitis (one eye). Macular scar
was the second most frequent complication and was
observed in five eyes (15.6%). Band keratopathy, CME,
macular hemorrhage, severe vitritis, retinal detachment,
macular hole, retinal fibrosis, and enucleated eye were other
causes leading to visual loss.
Discussion
Childhood uveitis is a potentially blinding disease charac-
terized by a chronic course and a high (76%) complication
rate [8]. Its association with systemic diseases is different
than adulthood and varies from one study to another
(Table 4). Race and ethnicity were reported to associate
with different patterns of uveitis, disease presentation, and
progression [9]. In most of the previous series [2, 8–14], the
majority of cases (24.2–60%) have been reported to be
idiopathic which is not consistent with our results.
Idiopathic uveitis was the second most common cause of
childhood uveitis in our series and has been identified in
16.5% of patients.
Juvenile idiopathic arthritis is the leading associated
systemic disease in most of the previous studies on
childhood uveitis [2, 3, 5, 8, 9, 15–17]. Furthermore, in
the study of Tugal-Tutkun et al. [3] and Kanski et al. [15],
Table 3 Complications secondary to childhood uveitis
N (eyes) %
Cataract 38 21.2
Glaucoma 32 17.8
Cystoid macular edema 17 9.5
Vitreus condensation 15 8.4
Optic atrophy 14 7.8
Band keratopathy 13 7.3
Posterior capsule opacification 5 2.8
Retinal detachment 5 2.8
Macular scar 5 2.8
Pupillary occlusion 3 1.8
Macular hole 1 0.6
Disc neovascularization 1 0.6
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childhood uveitis. Foster stated that in many tertiary referral
centers, up to 80% of anterior uveitis cases seen in children
are as a consequence of JIA [18]. JIA-associated uveitis
which has been observed in 6.6% of our patients was the
fifth most frequent cause of childhood-onset uveitis. This
relatively low frequency might be explained by genetic and
demographic factors playing role in the occurrence of JIA.
Previous studies from Turkey reported similar results
regarding the frequency of JIA-associated uveitis [12, 13].
Toxoplasmosis and pars planitis are reported to be other
frequent causes of childhood uveitis by several previous
studies [1, 3, 9, 11–13, 17]. Pars planitis is described as an
intermediate uveitis where there is a snowbank or snowball
formation occurring in the absence of an associated
infection or systemic disease [6]. Although idiopathic, this
specific uveitic entity was considered separately and not
included in idiopathic uveitis group. Pars planitis was the
leading cause of uveitis in our series with a rate of 24%.
Ocular toxoplasmosis has been observed in 13.2% and
made up the main cause of infectious uveitis in accordance
with previous studies. Other causes of infectious uveitis
were herpes, toxocara, and brucella infections. Infectious
uveitis made up 21.5% of our cases and this rate was
slightly lower than that of previous two studies from
Turkey reporting infectious causes in 27% and 30% of
pediatric cases [12, 13]. Infectious causes were identified in
5–24.3% of patients in other reports [4, 8, 14, 19].
Behçet’s disease-associated uveitis has been observed in
0.5–2.2% of patients with childhood-onset uveitis in non-
endemic areas [3, 15, 17]. Behçet’s disease which has been
observed in 16.5% of our patients was the second most
common cause of uveitis with idiopathic uveitis which has
exactly the same rate and number of patients. Additionally,
BD was the most commonly associated systemic disease.
This rate was even higher than that of Soylu et al. (11.1%)
which is the highest previously reported rate of ocular BD
in children [13]. BD was the fifth most common cause of
uveitic entity with a rate of 11% in another study from
Turkey by Kadayıfçılar et al. [12].
Less common causes of childhood uveitis in our series
were ankylosing spondilitis, Fuchs’ uveitis, trauma, multi-
focal choroiditis, FMF, VKH, sarcoidosis, and diabetes. A
higher prevalence of BD among FMF patients has been
described compared to the general population [20]. Fur-
thermore, a recent study of JIA patients in Turkey revealed
that 21 of 634 patients also had FMF [21]. In the light of
these data, FMF-associated uveitis is not an unexpected
condition, although not reported before. None of our
patients with FMF fulfilled the criteria of the International
Study Group for Behçet’s Disease. It is thought that these
patients may develop BD later in their life.
As its causes, forms of uveitis in children differ from
those in adults. Cunningham reviewed nine large studies
coming mostly from tertiary care facilities and found that
posterior uveitis was slightly more common than anterior
uveitis in children and accounted 40% to 50% of cases
versus 30% to 40%. Whereas in adults anterior uveitis was
more common (50%) than posterior uveitis (20%) [22].
However, a literature review by Holland and Stiehm
suggested that in population-based studies, the majority of
uveitis in children is restricted in anterior segment [23].
Consistently with this review and studies of Rosenberg et
al. (30.4%) [4], Smith et al. (44.6%), and Kump et al.
Table 4 Causes of pediatric uveitis (a summary of previously published series)
Perkins [10]; (%) Kanski [15]; (%) Giles [2]; (%) Tugal-Tutkun
[3]; (%)
Soylu [13]; (%) Kadayıfçılar
[12]; (%)
Current
Study
Pars planitis ––– 15.3 8.9 11.87 24
Idiopathic 43.3 5.8 60 21.5 34.4 24.2 16.5
Behcet’s disease – 0.5 – 0.7 11.1 10.96 16.5
Toxoplasmosis 20.6 –– 7.7 25.6 21 13.2
JIA 5.3 76.7 20 41.5 3.3 13.24 6.6
Herpetic uveitis 3.3 – 3.4 – 3.3 2.74 4.1
Toxocara 10 –– 3.1 1.1 3.2 3.3
Ankylosing spondylitis 0.6 12.7 1.3 0.7 – 1.83 4.1
Fuch’s uveitis 2.6 – 3.9 0.7 5.6 4.11 2.5
Brucella 0.8
Sarcoidosis 2.6 0.8 3.9 2.3 – 0.91 0.8
FMF 1.6
VKH 0.6 0.2 – 1.5 – 0.46 0.8
Tuberculosis 3.3 – 1.7 –– 1.37 –
JIA juvenile idiopathic arthritis, FMF Familial Mediterranean Fever, VKH Vogt–Koyanagi–Harada disease
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(31.4%) in our study. We should keep in mind that the
presentation of uveitis may change over time. Uveitis may
start at the anterior part of the eye and involve the vitreous
and the retina in course of time. Similarly, uveitis initially
called idiopathic may fit a particular category later. Thus,
the investigations should be repeated from time to time.
Childhood uveitis has been reported to be mostly bilateral
[9, 14]. On the contrary, unilateral involvement was slightly
more (52.1%) in our patients. We know that uveitis may
start at one eye and tend to be bilateral during the course of
the disease. It is certain that some of these patients will
have bilateral involvement later.
Childhood uveitis was described as a potentially blind-
ing disease associated with visual loss in 19%, complica-
tion(s) in 76%, and surgical intervention in 28% of patients
[8]. Rosenberg et al. [4] reported any kind of complications
in 94.6% of patients including macular complications
(70.9%), posterior synechia (54.7%), cataract (52%), optic
nerve complications (36.5%), band keratopathy (35.1%),
and glaucoma (33.1%). Optic atrophy (43.7%), cataract
(21.2%), glaucoma (17.8%), and cystoid macular edema
(9.5%) were the most common complications related to
uveitis in our pediatric patients. The rate of visual loss has
been reported to be 17.5% in another study [3]. In the
largest series of childhood uveitis, the proportion of patients
with vision ≤20/200 was 9.2 at baseline, 6.5% at 1 year,
15.1% at 5 years, and 7.7% at 10 years. Of our patients,
22.3% had at least one legally blind eye (a visual acuity
≤20/200) at final examination. Our higher rate for visual
loss might be explained with our higher incidence for BD.
Behçet’s disease-associated uveitis made up 37% of our
patients with blind eye. Among 20 patients with BD, ten
(50%) had at least one legally blind eye at final visit. A
significant number of these patients were referrals with
severe ocular involvement at presentation and their system-
ic therapy had been delayed. Most of these patients (14/20)
presented with panuveitis or posterior uveitis and relating
complications leading to visual loss. As reported by Tugal-
Tutkun and Urgancioglu, this group of patients needs a
prompt immunosuppressive therapy [24]. Blindness due to
childhood BD has been reported in 16.6% of patients in the
abovementioned study from Turkey [24] and in none of the
patients in a study from Germany [25]. It is known that
besides differences in geographic and ethnic origin of
patients, individual factors may play an important role in
variable expression and severity of the disease [20].
Posterior and panuveitis in children are considered poor
prognostic markers [9]. Consistently, most of our patients
(81.5%) with legally blind eye had either panuveitis or
posterior uveitis. The fact that 24% of patients already had
a visual loss at their first presentation to the clinic might be
another explanation for worse visual prognosis.
Conclusion
Childhood-onset uveitis has a relatively severe course and
led to visual loss in up to 22.3% of our patients. Difficulties
in diagnosing and treating the patients, high risk of
complications, and ambliopia are all challenges in this
particular population. Etiological distribution of uveitis is
an additional factor affecting the visual prognosis. Differ-
ently from studies of Western populations, Behçet’s disease
was the most commonly associated systemic disease in
childhood-onset uveitis in our population. This finding is
not surprising with the fact that Turkey has the highest
prevalence rate of the disease in the world. Our high rate of
BD-associated uveitis (16.5%) is the most important factor
explaining the high rate of permanent visual loss. Causes
and associated systemic diseases and also the course of
uveitis are closely related to differences in ethnic and
geographic origins of patients. To be aware of the causes
leading to uveitis in the pediatric population of a specific
community is very helpful for a prompt diagnosis and
treatment and also the prevention of severe complications.
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